COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Dr. Julia Cron has been appointed chief and vice chair of the Department of Obstetrics and Gynecology at NewYork-Presbyterian Lower Manhattan Hospital, effective Oct. 1.
Antibodies that guard against COVID-19 can transfer from mothers to babies while in the womb, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researcher.
The rationale for including pregnant and lactating women in early CDC-guided COVID-19 vaccination efforts in the United States was outlined in an opinion editorial.
The COVID-19 vaccine rollout is underway, bringing a sense of hope — as well as many questions about safety and who should get the vaccine. To help answer these questions, NewYork-Presbyterian experts address common concerns about the new Moderna and Pfizer-BioNTech COVID-19 vaccines and explain why they are safe.
Four distinguished Weill Cornell Medicine physician-scientists – Drs. Silvia Formenti, Barbara Hempstead, Lisa Newman and Laura Riley – have been selected as Crain’s Notable Women in Healthcare in New York City.
One of the most successful interventions in reducing infectious disease worldwide, vaccination still has limited effectiveness in protecting one group of patients – newborn infants.
